We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
New research shows work-related stress and health issues are rising, but flexibility and support from managers can help
Lars Lannfelt had a key role in developing a drug that has shown some promise in tackling Alzheimer’s
Dementia drug development, diagnostics and delivery still require much more investment
At what point does bargain hunting turn into shopping addiction?
Japanese company refuses to rule out possibility treatment contributed to brain bleeds
Shares fall 11% following two patient deaths in trials of lecanemab
The early death of an Alzheimer’s patient taking part in lecanemab trials sent shares down
Working-age people withdrawing from the workforce entirely raises concerns
We need to invest in the tools that enable people to stay well in work and prevent our workers from reaching crisis point
Culture and engagement are key to healthier staff
FT/Vitality survey finds evidence of a workforce in poor shape
Wealthier societies are increasingly troubled by the afflictions of people who live alone — and the young suffer more
Ill, overstretched staff are increasingly struggling to get treatment from an ill, overstretched service
Many countries are struggling with a rise in the numbers of people reporting problems with anxiety and depression
Two studies of antibody treatment gantenerumab fail to slow decline in people with early-stage disease
Access to large data sets means predictions are far more accurate in reducing risk
New analysis shows older workers are choosing to retire early rather than leaving their jobs due to ill health
The Kusnacht Practice treats royals, billionaires and celebrities struggling with mental health problems
Researchers focus on pathogens including Covid, herpes and Epstein-Barr virus
Waiting for inspiration to strike is a nice idea but delaying difficult tasks mostly leads to guilt and dread
Stanford university experiments offer ‘exciting’ system for modelling disorders and neural development
Crypto has a problem that gambling doesn’t: people often don’t know what they’re getting themselves into
Coroner ruling that online posts had ‘normalised’ British teenager’s condition puts pressure on tech companies
Pharma groups seek US regulatory approval as clinical trial shows monoclonal antibody treatment slowed disease
Thérèse Coffey’s lengthy wait to see a doctor highlights the imperative of tackling staff shortages
International Edition
